The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,886.00
Bid: 1,858.00
Ask: 1,864.00
Change: 18.00 (0.96%)
Spread: 6.00 (0.323%)
Open: 1,814.00
High: 1,918.00
Low: 1,814.00
Prev. Close: 1,868.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Joint Venture in China

31 Jul 2012 07:00

RNS Number : 8574I
Genus PLC
31 July 2012
 



For Immediate Release 31 July 2012

 

 

Genus plc

('Genus' or the 'Group')

 

Joint Venture in China with Leading Integrated Pork Producer

 

Genus, a leading global animal genetics company, is pleased to announce that its porcine genetics division, PIC, has signed a joint venture ("JV") agreement with Shaanxi Yangling BeSun Agricultural Group Co. ("BeSun''), a leading integrated pork producer in China, to partner in the operation of a large 4,250 sow nucleus farm in China's Shaanxi province.

 

The JV expands Genus' porcine business in China and is in line with its new corporate strategy which focuses on growing key markets and segments such as the Chinese integrated pork producer segment. China alone offers the largest opportunity in pork production, approximately half of the world pork consumption. Genus plans to increase its share of this large market from its small existing market share of c.1%. 

 

Genus will become a 49% partner in the JV through a cash investment of approximately £8.7m. The JV will own a recently completed state of the art nucleus farm, including air filtering to enhance disease prevention. Genus will provide over the next nine months pure line porcine stock from PIC's global high health pyramid to stock the farm. The JV farm will be managed by Genus. This will ensure that Genus' intellectual property will be protected. In addition, the arrangements enable the introduction of a royalty revenue model which is already in operation across Genus' porcine businesses in other key geographies.

 

The JV will produce grandparent sows with the output from the farm being used proportionally by the JV partners, approximately 50% each with BeSun using its proportion in its multiplication programme and Genus' share of the output providing important additional volume to support its growing sales of breeding animals in China. Once in full operation, the herd will underpin production of 10 million slaughter pigs per year.

 

Genus is continuing to pursue other JV opportunities in China to develop its porcine business further.

 

Commenting on the JV, Karim Bitar CEO said:

 

"Asia, and in particular China, is a strategic market for Genus. The JV announced today is in line with the growth strategy we announced in May and will provide us with an excellent stepping stone to expand our business whilst helping provide affordable, safe and high quality pork to Chinese consumers. We look forward to working with BeSun and achieving our shared objectives."

 

Commenting on the JV, Ms Yan, President of BeSun said:

 

"BeSun assessed several providers of porcine genetics, but we found that PIC pigs have the best performance on our farm. Most importantly, we explored leading porcine genetic companies around the world and found that PIC has the best resources, expertise and attitude to support their partners to be successful."

 

 

 

 

For further information please contact:-

 

Genus plc

Tel: 01256 345970

Karim Bitar, Chief Executive

John Worby, Finance Director

Buchanan

Tel: 0207 466 5000

Charles Ryland

 

 

This announcement is available on the Genus website, www.genusplc.com

 

 

About Genus

 

Genus creates advances to animal breeding through biotechnology and sells added value products for livestock farming and food producers. Its technology is applicable across all livestock species but is only commercialised by Genus in the dairy, beef and pork food production sectors.

 

Genus' worldwide sales are made in seventy countries under the trademarks "ABS" (dairy and beef cattle) and "PIC" (pigs) and comprise semen and breeding animals with superior genetics to those animals currently in production. Customers' animals produce offspring with greater production efficiency, milk and meat output and quality, and use these to supply the global dairy and meat supply chain.

 

The Group's competitive edge has been created from the ownership and control of proprietary lines of breeding animals, the biotechnology used to improve them and its global production, technical service and distribution network.

 

With headquarters in Basingstoke, United Kingdom, Genus companies operate in thirty countries on six continents, with research laboratories located in Madison, Wisconsin, USA.

 

 

 

About Genus PIC

 

PIC is the global leader in providing genetically superior pig breeding stock and technical support for maximising genetic potential to commercial pork producers. Operating for 50 years, PIC's success is due to its concentration on and significant investment in all aspects of genetics, technology and health.

 

About BeSun

 

BeSun is a leading integrated pig producer. It has an animal feed business producing approximately 150,000 tonnes of feed each year. In addition, it farms 15,000 sows and operates its own slaughter facilities and 90 retail outlets in China's Shaanxi province. It plans to increase its production base to support an annual kill of 3.9 million pigs within 10 years.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
JVEFMGFNNGRGZZM
Date   Source Headline
1st May 20241:59 pmRNSTotal Voting Rights
22nd Feb 20247:00 amRNSInterim Results
15th Feb 20247:00 amRNSTrading Update
1st Feb 20244:24 pmRNSBlock listing Interim Review
1st Feb 20244:21 pmRNSTotal Voting Rights
12th Dec 20237:00 amRNSNon-Executive Director Appointment
22nd Nov 20231:08 pmRNSResult of AGM
22nd Nov 20237:00 amRNSAGM Trading Update
1st Nov 20234:46 pmRNSTotal Voting Rights
1st Nov 20237:00 amRNSCapital Markets Event
13th Oct 20237:00 amRNSAnnual Report and Annual General Meeting
5th Oct 202310:19 amRNSPos. determination-PRRS resistant pigs-Colombia
2nd Oct 202311:12 amRNSTotal Voting Rights
15th Sep 20231:07 pmRNSDirector/PDMR Shareholding
15th Sep 202310:04 amRNSDirector/PDMR Shareholding
7th Sep 20237:00 amRNSPreliminary Results
25th Aug 20238:35 amRNSNotification of Major Holdings
23rd Aug 20239:25 amRNSDirectorate Change
1st Aug 202311:41 amRNSBlock listing Interim Review
1st Aug 202311:36 amRNSTotal Voting Rights
3rd Jul 202311:02 amRNSTotal Voting Rights
16th Jun 20235:33 pmRNSNational Milk Records plc - Form 8.3
16th Jun 20235:10 pmRNSForm 8.3 (OPD) - National Milk Records plc
8th Jun 20233:51 pmRNSDirector/PDMR Shareholding
7th Jun 20235:11 pmRNSNotification of Major Holdings
7th Jun 20235:08 pmRNSNotification of Major Holdings
5th Jun 20239:12 amRNSAdditional Listing
24th May 20234:54 pmRNSNotification of Major Holdings
18th May 20231:32 pmRNSDirector/PDMR Shareholding
16th May 20236:16 pmRNSDirector/PDMR Shareholding
16th May 20237:00 amRNSTrading Update
9th May 20234:30 pmRNSNotification of Major Holdings
3rd May 20238:44 amRNSTotal Voting Rights
2nd May 20237:00 amRNSShare Award for Incoming CEO
3rd Apr 202311:27 amRNSTotal Voting Rights
3rd Apr 20237:00 amRNSAppointment of Chief Executive Officer Designate
21st Mar 20232:58 pmRNSApplication for Block Listing
6th Mar 202312:53 pmRNSNotification of Major Holdings
2nd Mar 20231:51 pmRNSNotification of Major Holdings
1st Mar 20232:20 pmRNSNotification of Major Holdings
24th Feb 20235:13 pmRNSDirector/PDMR Shareholding
24th Feb 202311:39 amRNSNotification of Major Holdings
23rd Feb 20239:33 amRNSReplacement: Interim Results
23rd Feb 20237:00 amRNSChief Executive Officer Retirement
23rd Feb 20237:00 amRNSInterim Results
21st Feb 20235:03 pmRNSNotification of Major Holdings
10th Feb 20232:08 pmRNSNotification of Major Holdings
1st Feb 202310:00 amRNSBlock listing Interim Review
23rd Nov 20221:02 pmRNSResult of AGM
23rd Nov 20227:00 amRNSAGM Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.